Skip to main content
. 2019 Oct 10;9:14569. doi: 10.1038/s41598-019-51270-1

Figure 6.

Figure 6

Activation of the BMP signaling pathway protects glioma cells from cytotoxic injury. (A) Cell viability following treatment of G144 cells with temozolomide and radiation, with BMP4 and LY364947 or TGF-β1 and noggin, compared to control (n = 3, *p < 0.05). (B) Cell viability following treatment of G179 cells with temozolomide and radiation, with BMP4 and LY364947 or TGF-β1 and noggin, compared to control (n = 3, *p < 0.05). (C) Cell viability following treatment of BT046 cells with temozolomide and radiation, with BMP4 and LY364947 or TGF-β1 and noggin, compared to control (n = 3, *p < 0.05). (D) Western blot analysis for phosphorylated ATM (pATM), ATM, and MGMT, in BT046 cells treated with temozolomide and radiation, with BMP4 and LY364947 or TGF-β1 and noggin, compared to control. (E) Western blot analysis for phosphorylated H2αX in BT046 cells treated with temozolomide and radiation, with BMP4 and LY364947 or TGF-β1 and noggin, compared to control. (F) Kaplan-Meier curve for survival in NSG mice following intracranial transplantation with U251 or U251-TR cells (*p < 0.01). (G) Circos plot of expression data generated by microarray analysis of U251 cells. (H) Circos plot of expression data generated by microarray analysis of U251-TR cells.